High pretreatment disease burden as a risk factor for infectious complications following CD19 chimeric antigen receptor T‐cell therapy for large B‐cell lymphoma

Abstract Infection has emerged as the chief cause of non‐relapse mortality (NRM) post CD19‐targeting chimeric antigen receptor T‐cell therapy (CAR‐T) therapy. Even though up to 50% of patients may remain infection‐free, many suffer multiple severe, life‐threatening, or fatal infectious events. The p...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Maeve A. O'Reilly, Lorna Neill, Simon M. Collin, Neil Stone, Deborah Springell, Jeremy Mensah, Kathleen P. L. Cheok, Katarzyna Jalowiec, Reuben Benjamin, Andrea Kuhnl, Claire Roddie, Robin Sanderson
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Wiley 2024-01-01
Reeks:	HemaSphere
Online toegang:	https://doi.org/10.1002/hem3.29
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!